Profound Medical Corp. Statistics
Share Statistics
Profound Medical Corp. has 24.66M shares outstanding. The number of shares has increased by 14.58% in one year.
Shares Outstanding | 24.66M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.22% |
Owned by Institutions (%) | n/a |
Shares Floating | 21.32M |
Failed to Deliver (FTD) Shares | 37 |
FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 340.53K, so 1.38% of the outstanding shares have been sold short.
Short Interest | 340.53K |
Short % of Shares Out | 1.38% |
Short % of Float | 1.6% |
Short Ratio (days to cover) | 11.36 |
Valuation Ratios
The PE ratio is -6.2 and the forward PE ratio is -9.05.
PE Ratio | -6.2 |
Forward PE | -9.05 |
PS Ratio | 24.62 |
Forward PS | 6.7 |
PB Ratio | 5.69 |
P/FCF Ratio | -7.95 |
PEG Ratio | n/a |
Enterprise Valuation
Profound Medical Corp. has an Enterprise Value (EV) of 161.66M.
EV / Earnings | -5.66 |
EV / Sales | 22.46 |
EV / EBITDA | -6.04 |
EV / EBIT | -5.65 |
EV / FCF | -7.25 |
Financial Position
The company has a current ratio of 6.58, with a Debt / Equity ratio of 0.23.
Current Ratio | 6.58 |
Quick Ratio | 5.48 |
Debt / Equity | 0.23 |
Total Debt / Capitalization | 18.56 |
Cash Flow / Debt | -3.14 |
Interest Coverage | -37.16 |
Financial Efficiency
Return on equity (ROE) is -0.92% and return on capital (ROIC) is -72.82%.
Return on Equity (ROE) | -0.92% |
Return on Assets (ROA) | -0.65% |
Return on Capital (ROIC) | -72.82% |
Revenue Per Employee | 54.95K |
Profits Per Employee | -218.08K |
Employee Count | 131 |
Asset Turnover | 0.16 |
Inventory Turnover | 0.4 |
Taxes
Income Tax | -128.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -22.37% in the last 52 weeks. The beta is 0.83, so Profound Medical Corp.'s price volatility has been higher than the market average.
Beta | 0.83 |
52-Week Price Change | -22.37% |
50-Day Moving Average | 7.78 |
200-Day Moving Average | 8.35 |
Relative Strength Index (RSI) | 41.96 |
Average Volume (20 Days) | 66.36K |
Income Statement
In the last 12 months, Profound Medical Corp. had revenue of $7.20M and earned -$28.57M in profits. Earnings per share was $-1.35.
Revenue | 7.20M |
Gross Profit | 4.38M |
Operating Income | -28.62M |
Net Income | -28.57M |
EBITDA | -26.78M |
EBIT | -28.62M |
Earnings Per Share (EPS) | -1.35 |
Balance Sheet
The company has $26.21M in cash and $7.94M in debt, giving a net cash position of $18.27M.
Cash & Cash Equivalents | 26.21M |
Total Debt | 7.94M |
Net Cash | 18.27M |
Retained Earnings | -217.93M |
Total Assets | 42.23M |
Working Capital | 34.21M |
Cash Flow
In the last 12 months, operating cash flow was -$22.30M and capital expenditures $0.19, giving a free cash flow of -$22.30M.
Operating Cash Flow | -22.30M |
Capital Expenditures | 0.19 |
Free Cash Flow | -22.30M |
FCF Per Share | -1.05 |
Margins
Gross margin is 60.87%, with operating and profit margins of -397.5% and -396.85%.
Gross Margin | 60.87% |
Operating Margin | -397.5% |
Pretax Margin | -398.62% |
Profit Margin | -396.85% |
EBITDA Margin | -372.01% |
EBIT Margin | -397.5% |
FCF Margin | -309.72% |
Dividends & Yields
PROF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -18.27% |
FCF Yield | -12.23% |
Analyst Forecast
The average price target for PROF is $11.4, which is 54.3% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.4 |
Price Target Difference | 54.3% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Oct 16, 2019. It was a backward split with a ratio of 1:10.
Last Split Date | Oct 16, 2019 |
Split Type | backward |
Split Ratio | 1:10 |
Scores
Altman Z-Score | 0.47 |
Piotroski F-Score | 4 |